Epstein-Barr Virus Positive Follicular Lymphoma of Lymph Node

Article information

Abstract

INTRODUCTION

Epstein-Barr virus (EBV) is a member of the herpes virus family and is associated with a number of lymphoid and non-lymphoid malignancies, particularly the development of certain lymphomas including endemic Burkitt’s lymphoma, some classical Hodgkin’s lymphomas, diffuse large B-cell lymphoma (DLBCL), extranodal NK/T cell lymphoma, and angioimmunoblastic T-cell lymphoma [1]. However, rare cases of follicular lymphoma (FL) with EBV infection and a few mimicking cases has been reported [2-6]. Herein, we report a rare case of EBV associated FL of lymph node with its review of literature.

CASE REPORT

A 59-year-old woman, who had no medical history, was presented at our hospital due to an incidentally discovered left axillary mass. She had no other clinical symptoms. The initial complete blood count showed following results: white blood cells, 9.7 K/μL (neutrophils, 80.6%; lymphocytes, 11.3%; monocytes, 6.1%); hemoglobin, 11.9 g/dL (normal range, 12 to 16 g/dL); and platelets, 361 K/μL. Serum lactate dehydrogenase had slightly increased to 223 U/L (normal range, 106 to 211 U/L), but other laboratory findings were unremarkable. A neck computed tomography scan revealed multiple well-defined, homogeneous enhancing, and enlarged lymph nodes in the left axilla (Fig. 1A). A subsequent positron emission tomography-computed tomography scan revealed multiple enlarged lymph nodes in the left axilla (levels I and II) with hypermetabolism (maximum standardized uptake value [SUV], 14.64; average SUV, 4.70). Other hypermetabolic lymphadenopathy was detected in the mesentery and left external iliac chain with no suspicious foci at other organs that were compatible with lymphoma. An excisional biopsy of the left axillary mass was performed, and it was histologically confirmed as FL grade 3a. She received the R-CHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, vincristine, prednisone) chemotherapy and was followed for 9 months without any complications.

Fig. 1.

Radiographic findings. (A) Computed tomography shows multiple, well-circumscribed, enlarged nodes in the left axilla (levels I and II) (arrowhead). (B) Positron emission tomography-computed tomography reveals hypermetabolic foci in the left axilla and mesentery.

The lymph nodes microscopically consisted of small areas of reactive follicles on the low power view (Fig. 2A, left lower side). Other areas showed variously sized follicles with a preserved mantle zone (Fig. 2A, left upper side), and predominant areas containing vague follicles with peripheral fading and coalescence (Fig. 2A, right). Some follicles were separated by prominent lymphocytic mantle, and the neoplastic follicles showed a lack of cellular polarity (Fig. 2B). The neoplastic follicles contained mixed small cleaved cells without nucleoli (centrocytes) and larger non-cleaved cells with moderate cytoplasm, open chromatin, and multiple nucleoli (centroblasts) (Fig. 2C). More than 15 centroblasts/high power field (HPF) were present in the neoplastic germinal center (GC), consistent with grade 3A FL. In addition, no diffuse area that fulfilled the criteria for diffuse large B cell lymphoma with FL was detected in any of the excised lymph nodes. Immunohistochemical staining showed tumor cells positive for CD20 and Bcl-6 and negative for CD3, CD5, CD10, Bcl-2, and cyclin D-1. The Ki-67 proliferation index increased in the neoplastic follicles with loss of polarity (Fig. 2D-H). An association with EBV was clearly demonstrated by the neoplastic follicles and tumor cells with EBV in situ hybridization (EBER) (Fig. 2I).

Fig. 2.

Microscopic findings of Epstein-Barr virus (EBV)-positive follicular lymphoma. (A) One of the lymph nodes shows a reactive hyperplastic area (left lower side) and an area with lymphomatous change (left upper side). The other node shows vague follicles with peripheral fading and coalescence (right side) (H&E, × 12.5). (B) Some neoplastic follicles are surrounded by a thick lymphocytic mantle with a lack of cellular polarization (H&E, × 40). (C) The tumor cells consist of mixed centrocytes and centroblasts (H&E, × 400). (D-H) The neoplastic follicles are negative for CD3 (D) and positive for CD20 (E), and the Ki-67 (F) proliferation index increased in the neoplastic follicles (left upper) with loss of polarity compared to those of reactive follicles (left lower). Tumor cells are for Bcl-2 (G) and CD10 negative (H). (I) The neoplastic follicles were positive on in situ hybridization for EBV. Inset: EBV-positive tumor cells (× 100).

DISCUSSION

EBV is a member of herpes virus with overall seroprevalence >90% in all adults. A spectrum of EBV-related diseases exists, such as a chronic active EBV infection and EBV-related epithelial, mesenchymal, or lymphoid malignancies [7].

Despite the growing prevalence of EBV-associated lymphomas including the heterogeneous group of B-cell lymphomas (Burkitt’s lymphoma, DLBCL, primary effusion lymphoma, etc.) and NK/T-cell lymphoma, the exact roles of EBV in lymphomagenesis remain unclear [1]. Moreover, since Seite et al. [6] suggested that EBV infection did not contribute significantly in Bcl-2 activation in the FL, an association between EBV infection and FL, and the optimal management of EBV-associated FL have been unsatisfactory. Although its incidence is extremely rare, there have been several studies including EBV-associated FL [4,5,8]. A study by Ishtiaq et al. [4] included only two EBV-positive cases out of 11 cases of FL. Sasikala et al. [9] reviewed the EBV-positive non-Hodgkin’s lymphomas including six EBV-positive cases out of 17 cases with FL; the characteristics of EBV-positive FL included 48 years of median age (range, 34 to 70 years), 10:7 of sex ratio (male:female) and all type A strain [8]. However, EBV-associated FL has not yet been reported in Korea to our best knowledge.

Histologically, there can be several differential diagnoses in the present case, including EBV infected follicular hyperplasia and early phase of EBV-positive DLBCL or EBV-positive DLBCL with FL. Although Bcl-2 was negative in the neoplastic follicles, malignant transformation was histologically noted on the enlarged GCs of the present case, and these microscopic findings fulfilled the FL grade 3A criteria; many neoplastic follicles with transformed GC contained atypical large lymphoid cells (>15 centroblasts/HPF) with loss of polarity on Ki-67 staining. Although FL has been associated with Bcl-2 and CD10 positivity in GCs, several reports indicate that grade 3 FLs can be negative for Bcl-2 (particularly in high grade FL, <50% of FL grade 3) and CD10 [9,10]. According to Roughan et al. [11], EBV infected cells are known to express common GC markers (CD10 and Bcl-6) and overexpress Bcl-2. However, the immunohistochemical profile of EBV-infected neoplastic B cells is not well characterized. In the present case, EBV was detected only in the neoplastic follicles, and no EBV-positive cells were identified in the non-neoplastic area, strongly suggesting an association between FL and the EBV infection.

Similar to a case reported by Gru et al. [2], an acute EBV infection can masquerade as FL in situ. Although some of the follicles were Bcl-2 and CD10 positive in their case, the microscopic features of lymphomatous transformation were not definite, and EBV was only detected in a few scattered cells in their case. Considering the histological findings and additional studies of the present case (high grade GCs with marked EBER expression in neoplastic GCs and no expression in normal GCs), the association between FL and EBV was more significant and excludes the possibility of an acute EBV infection.

Early phase EBV-positive DLBCL could also have been considered as a diagnosis in our case, which was described by de la Hera Magallanes et al. [3] EBV-positive lymphoproliferative disorders are a broad spectrum of diseases from EBV-associated reactive lymphoid hyperplasia to EBV-positive DLBCL, and these B-cell neoplasms can also show various morphological microscopic findings from Hodgkin-like features to monomorphic large B-cell lymphoma-like features. However, our case showed only a follicular growth pattern in the overall excised lymph nodes, and diffuse growth of neoplastic B-cells was not clearly identified. Therefore, the possibility of DLBCL with FL was excluded.

To conclude, rare cases of FL associated with EBV have been reported. Awareness of EBV infection in a patient with FL could contribute to early detection and treatment of this possibly life-threatening disorder. We report a rare case of EBV-positive FL of lymph nodes, hoping that more accumulated cases will support further evaluation for an association between EBV and FL.

Article information Continued